AB
Artax Biopharma, Inc.
SEC filingPharmaceuticals · Cambridge, MA
Amount raised$19Msold at filing
Total offering$19M
Investors in the raise30count reported to the SEC
FiledMay 5, 2026first sale Jul 31, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Joe W. SuarezExecutive Officer
Andre W. HoekemaDirector
Maria W. NicholExecutive Officer
Alan W. WaltsDirector
Damia W. Tormo, Ph.D.Director
Gino W. SantiniDirector
Casper W. BreumDirector
Raj W. ParekhDirector
Robert W. Armstrong, Ph.D.Executive Officer, Director
Executive officers, directors and promoters as listed on the Form D.